Market Closed -
Toronto S.E.
02:55:01 2024-05-06 pm EDT
|
5-day change
|
1st Jan Change
|
0.25
CAD
|
0.00%
|
|
+8.70%
|
-16.67%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
20.1
|
38.63
|
38.26
|
15.89
|
19.51
|
15.78
|
Enterprise Value (EV)
1 |
20.1
|
38.63
|
38.26
|
15.89
|
19.51
|
15.78
|
P/E ratio
|
-21.3
x
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.15
x
|
2.23
x
|
1.8
x
|
0.56
x
|
0.75
x
|
0.53
x
|
EV / Revenue
|
1.15
x
|
2.23
x
|
1.8
x
|
0.56
x
|
0.75
x
|
0.53
x
|
EV / EBITDA
|
-
|
83.6
x
|
8,520
x
|
24.1
x
|
13.2
x
|
7.89
x
|
EV / FCF
|
-
|
12,854,128
x
|
17,549,211
x
|
16,740,388
x
|
-
|
-
|
FCF Yield
|
-
|
0%
|
0%
|
0%
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
61,464
|
65,612
|
79,295
|
86,209
|
86,209
|
86,209
|
Reference price
2 |
0.4250
|
0.7500
|
0.6100
|
0.2500
|
0.3000
|
0.2500
|
Announcement Date
|
3/12/20
|
3/11/21
|
3/10/22
|
3/8/23
|
3/7/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
17.4
|
17.31
|
21.28
|
28.21
|
26.18
|
29.8
|
EBITDA
1 |
-
|
0.462
|
0.00449
|
0.6583
|
1.478
|
2
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-0.0200
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
3.006
|
2.18
|
0.9495
|
-
|
-
|
FCF margin
|
-
|
17.36%
|
10.24%
|
3.37%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
650.54%
|
48,550.33%
|
144.23%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/12/20
|
3/11/21
|
3/10/22
|
3/8/23
|
3/7/24
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
5.263
|
5.91
|
7.297
|
6.987
|
7.142
|
6.78
|
6.396
|
6.677
|
6.554
|
6.552
|
6.4
|
6.6
|
8.1
|
8.7
|
EBITDA
1 |
0.0591
|
-0.0589
|
0.2276
|
0.034
|
0.3255
|
0.0713
|
0.086
|
0.3861
|
0.4342
|
0.5713
|
0.4
|
0.4
|
0.5
|
0.6
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/4/21
|
3/10/22
|
5/12/22
|
8/12/22
|
11/10/22
|
3/8/23
|
5/11/23
|
8/10/23
|
11/9/23
|
3/7/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
3.01
|
2.18
|
0.95
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/12/20
|
3/11/21
|
3/10/22
|
3/8/23
|
3/7/24
|
-
|
Last Close Price
0.183
USD Average target price
0.438
USD Spread / Average Target +139.31% Consensus |
1st Jan change
|
Capi.
|
---|
| -16.67% | 15.75M | | -2.86% | 3.01B | | 0.00% | 1.97B | | +5.43% | 1.59B | | +54.96% | 643M | | -4.73% | 511M | | -33.81% | 368M | | -26.04% | 147M | | -11.94% | 142M | | +1.92% | 67.85M |
Home Healthcare Services
|